Latest News and Press Releases

Applied Biologics introduces ECM Preservation Technology™ (EPT™), the proprietary manufacturing platform behind XWRAP®.

Applied Biologics' VA FSS contract shifts to Evergreen structure, enabling potential XWRAP® access for up to 20 years.

Dublin, July 03, 2026 (GLOBE NEWSWIRE) -- The "Biologic Therapies for Wound Care: Technologies and Global Markets" has been added to ResearchAndMarkets.com's offering. The global wound care...

Applied Biologics expands its national commercial organization to support XWRAP® growth and future pipeline commercialization.

Applied Biologics completes translational study showing XWRAP® exhibits favorable wound-healing biology vs. conventional placental tissue processing.

Applied Biologics presents interim CAMPX Trial data at SAWC Spring 2026, highlighting encouraging wound closure trends for XWRAP® in diabetic foot ulcers.

Dublin, May 05, 2026 (GLOBE NEWSWIRE) -- The "Superabsorbents Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036" has been added to ...

Dublin, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The "Negative Pressure Wound Therapy (NPWT) Devices: Global Markets" has been added to ResearchAndMarkets.com's offering. The global market for...

Dublin, Sept. 26, 2025 (GLOBE NEWSWIRE) -- The "United States Wound Care Market Report by Wound Type, Products, Application, End User, States and Company Analysis, 2025-2033" report has been added...

FORT WORTH, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and...